| Global Immunization Newsletter - January/February 2026 After the WHO Executive Board: Charting the next five years of immunizationAt the 158th session of the WHO Executive Board (2–7 February 2026), one message came through clearly: immunization remains one of the most powerful and cost-effective ways to save lives, protect communities, and strengthen health systems. Against a backdrop of significant global shifts—including financial constraints, governance reform, and evolving partnerships—Member States and partners reaffirmed the Immunization Agenda 2030 (IA2030) as the shared global strategy and partnership umbrella guiding immunization efforts in the years ahead. Discussions underscored the need for sharper prioritization, stronger accountability, and closer collaboration across the global health ecosystem. Looking to the next five years, the focus is firmly on turning ambition into impact. EB discussions emphasized reaching zero-dose children and under-immunized populations, embedding immunization within primary health care and universal health coverage, rebuilding trust and demand, and strengthening country ownership in a constrained financing environment. Member States also highlighted the importance of effective governance, sustainable financing, and meaningful engagement with partners and non-state actors. Working alongside partners such as Gavi, UNICEF, and civil society, WHO is being called upon to lead with clarity and coordination—ensuring that immunization remains central to resilient health systems and that no one, anywhere, is left unprotected. Upcoming meetings
Q&A Feature: Immunization Agenda 2030 As IA2030 reaches its midpoint, how would you assess global progress so far, and where are we most off track? Trusted answers on vaccines Exploring WHO’s new information hubIn an era where misinformation about vaccines can spread as quickly as disease outbreaks themselves, restoring public trust in vaccination is more important than ever. Stories Next-generation flu vaccines could save millions of livesNext-generation influenza vaccines could prevent 18 billion cases and save 6.2 million lives by 2050, according to a recent World Health Organization (WHO) assessment. 4-Dose RTS,S boosts protection against malariaWHO recommends two malaria vaccines, RTS,S and R21, to prevent malaria in children. Pilot programmes in Ghana, Kenya and Malawi reduced child deaths by 13%. New vaccine customs classificationThirty-eight new customs codes for human vaccines and other essential medical products will enter into the Harmonized System (HS) on 1 January 2028 Statement: Hep B birth dose vaccine trial in Guinea-BissauWHO reaffirms the hepatitis B birth dose vaccine as essential and proven, and raises serious scientific and ethical concerns about the proposed trial in Guinea-Bissau. Bangladesh introduces typhoid conjugate vaccinesBangladesh introduced typhoid conjugate vaccines last October through a nationwide campaign reaching more than 42 million children New resources Past meetings
Contributions Contribute to the next issue of the GINTo contribute to the next update, please click on this link to submit an article by the 20th of March. |
Wednesday, March 4, 2026
Global Immunization insights_January/February 2026
Subscribe to:
Post Comments (Atom)













No comments:
Post a Comment